Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by RichyRich$on Mar 27, 2016 12:24pm
141 Views
Post# 24702986

RE:RE:Competition is Fierce ...

RE:RE:Competition is Fierce ...Actually, that patch only lasts for 10 hours for mice according to that article. The Pharmacy company that partners with them would love that, making more money off patches. It most likely only lasts that long because the islets aren't in an environment to last long when out of the package and refrigerator and no blood supply. They actually initially had different patent last year with insulin attached to a soluable that releases only when blood sugar rising. But they ditched that plan and thought, why not add the actual insulin islet cells since they're so easy to make in a lab with stemcell growing. But I mention this also as a positive for Sernova, because ViaCyte's capsules will only last one year. So any diabetic would prefer a daily patch versus going under the knife for a surgery every year to have a bunch of new ViaCyte capsules taken out and reinserted every year. I believe this patch invention will wipe out any encapsulation cures that don't last longterm, such as Viacyte's.  This would give Sernova's Cell Pouch the upper hand if able to survive long-term. Which is what they believe. We will know soon, as their next phase of human trials with Sertolin immunity protection will be added along with the islets into the pouch. Diabetics might be willing to deal with a surgery for new capsules if once every 5 years, instead of a daily patch. I'm hoping Sernova's Cell Pouch will be completely long-term lasting beyond 5 years. This would give Sernova a good comparison to base their pricing. If diabetics see that a daily patch is extremely expensive, they'll be willing to pay big bucks for a one-time procedures with no on-going costs and inconvenience. Plus other hormone therapy in the future... not just insulin.
Bullboard Posts